Abiraterone is an androgen biosynthesis inhibitor used to treat metastatic prostate cancer. It blocks CYP17A1 enzyme, reducing androgen production which fuels prostate cancer growth. It is usually administered with prednisone to mitigate side effects. It's an oral medication used in advanced stages of the disease.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Abiraterone and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Abiraterone impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Abiraterone-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.